Is a Chlamydia vaccine a reality?

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 16, Issue 6, 2002, Pages 889-900

  Christiansen, Gunna ^a   Birkelund, Svend ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

Animal models; Cell mediated immune response; Chlamydia trachomatis; Humoral immune response; Recombinant proteins; Vaccine

Indexed keywords

BACTERIAL VACCINE; DNA VACCINE; PROTEIN VACCINE; RECOMBINANT PROTEIN; RECOMBINANT VACCINE; UNCLASSIFIED DRUG; BACTERIUM ANTIBODY;

CELLULAR IMMUNITY; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; DISEASE COURSE; ECTOPIC PREGNANCY; FEMALE INFERTILITY; HUMAN; HUMORAL IMMUNITY; HYPERSENSITIVITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEROTYPE; SEXUALLY TRANSMITTED DISEASE; SIDE EFFECT; VACCINE PRODUCTION; ANIMAL; BIOSYNTHESIS; FEMALE; IMMUNOLOGY;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; HUMANS; IMMUNITY, CELLULAR;

EID: 0036884536     PISSN: 15216934     EISSN: None     Source Type: Journal    
DOI: 10.1053/beog.2002.0324     Document Type: Article

References (57)

1. Pearce JH & Gaston JSH. Chlamydia. In Susmann M (ed.) Molecular Medical Microbiology, pp 1825-1864. San Diego: Academic Press, 2001.
2. Stephens RS, Sanchez-Pescador R, Wagar EA et al. Diversity of Chlamydia trachomatis major outer membrane protein genes. Journal of Bacteriology 1987; 169: 3879-3885.
3. Wang SP & Grayston JT. Human serology in Chlamydia trachomatis infection with microimmunofluorescence. Journal of Infectious Diseases 1974; 130: 388-397.
4. Larsen B, Birkelund S, Mordhorst CH et al. The humoral immune response to Chlamydia trachomatis in patients with acute reactive arthritis. British Journal of Rheumatology 1994; 33: 534-540.
5. Mårdh PA, Lind I, Svensson L et al. Antibodies to Chlamydia trachomatis, Mycoplasma hominis, and Neisseria gonorrhoeae in sera from patients with acute salpingitis. British Journal of Venereal Disease 1981; 57: 125-129.
6. Westrom L. Effect of acute pelvic inflammatory disease on fertility. American Journal of Obstetrics and Gynecology 1975; 121: 707-713.
7. Eggert-Kruse W, Rohr G, Demirakca T et al. Chlamydial serology in 1303 asymptomatic subfertile couples. Human Reproduction 1997; 12: 1464-1475.
8. Moller BR & Mårdh PA. Experimental salpingitis in grivet monkeys by Chlamydia trachomatis. Modes of spread of infection to the Fallopian tubes. Acta Pathologica Microbiologica Scandinavica 1980; 88: 107-114.
9. Wang SP & Grayston JT. Human serology in Chlamydia trachomatis infection with microimmunofluorescence. Journal of Infectious Diseases 1974; 130: 388-397.
10. Hatch TP. Disulfide cross-linked envelope proteins: the functional equivalent of peptidoglycan in chlamydiae? Journal of Bacteriology 1996; 178: 1-5.
11. Mygind P, Christiansen G & Birkelund S. Topological analysis of Chlamydia trachomatis L2 outer membrane protein 2. Journal of Bacteriology 1998; 180: 5784-5787.
12. Sanchez-Campillo M, Bini L, Comanducci M et al. Identification of immunoreactive proteins of Chlamydia trachomatis by Western blot analysis of a two-dimensional electrophoresis map with patient sera. Electrophoresis 1999; 20: 2269-2279.
13. Morrison RP, Belland RJ, Lyng K & Caldwell HD. Chlamydial disease pathogenesis. The 57-kD chlamydial hypersensitivity antigen is a stress response protein. Journal of Experimental Medicine 1989; 170: 1271-1283.
14. Persson K, Osser S, Birkelund S et al. Antibodies to Chlamydia trachomatis heat shock proteins in women with tubal factor infertility are associated with prior infection by C. trachomatis but not by C. pneumoniae. Human Reproduction 1999; 14: 1969-1973.
15. Loomis WP & Starnbach MN. T cell responses to Chlamydia trachomatis. Current Opinion in Microbiology 2002; 5: 87-91.
16. Kim SK & DeMars R. Epitope clusters in the major outer membrane protein of Chlamydia trachomatis. Current Opinion in Immunology 2001; 13: 429-436.
17. Goodall JC, Beacock-Sharp H, Deane KH & Gaston JS. Recognition of the 60 kilodalton cysteine-rich outer membrane protein OMP2 by CD4(+) T cells from humans infected with Chlamydia trachomatis. Clinical and Experimental Immunology 2001; 126: 488-493.
18. + T lymphocytes by screening an expression library. European Journal of Immunology 2001; 31: 1513-1522.
19. Kinnunen A, Paavonen J & Surcel HM. Heat shock protein 60 specific T-cell response in chlamydial infections. Scandinavian Journal of Immunology 2001; 54: 76-81.
20. Scidmore-Carlson MA, Shaw El, Dooley CA et al. Identification and characterization of a Chlamydia trachomatis early operon encoding four novel inclusion membrane proteins. Molecular Microbiology 1999; 33: 753-765.
21. Zhong G, Fan P, Ji H et al. Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors. Journal of Experimental Medicine 2001; 193: 935-942.
22. Stephens RS, Kalman S, Lammel C et al. Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science 1998; 282: 754-759.
23. Hsia RC, Pannekoek Y, Ingerowski E & Bavoil PM. Type III secretion genes identify a putative virulence locus of Chlamydia. Molecular Microbiology 1997; 25: 351-359.
24. + CTLs with HLA class I tetramers. Journal of Immunology 2000; 165: 7285-7292.
25. + T cells recognize an inclusion membrane-associated protein from the vacuolar pathogen Chlamydia trachomatis. Proceedings of the National Academy of Sciences of the USA 2001; 98: 1160-1165.
26. Dhir SP, Agarwal LP, Detels R et al. Field trial of two bivalent trachoma vaccines in children of Punjab Indian villages. American Journal of Ophthalmology 1967; 63: 1639-1644.
27. Clements C, Dhir SP, Grayston JT & Wang SP. Long term follow-up study of a trachoma vaccine trial in villages of Northern India. American Journal of Ophthalmology 1979; 87: 350-353.
28. Wang, SP, Grayston JT & Alexander ER. Trachoma vaccine studies in monkeys. American Journal of Ophthalmology 1967; 63: 1615-1630.
29. Morrison RP, Lyng K & Caldwell HD. Chlamydial disease pathogenesis. Ocular hypersensitivity elicited by a genus-specific 57-kD protein. Journal of Experimental Medicine 1989; 169: 663-675.
30. Patton DL, Sweeney YT & Kuo C-C. Demonstration of delayed hypersensitivity in Chlamydia trachomatis in monkeys: a pathogenic mechanism of tubal damage. Journal of Infectious Diseases 1994; 169: 680-683.
31. Rank RG. Animal models of urogenital infections. Methods in Enzymology 1994; 235: 83-93.
32. van Voorhis WC, Barrett LK, Sweeney YT et al. Repeated Chlamydia trachomatis infection of Macaca nemestrina fallopian tubes produces a Th1-like cytokine response associated with fibrosis and scarring. Infection and Immunity 1997; 65: 2175-2182.
33. Peeling RW, Patton DL, Cosgrove Sweeney YT et al. Antibody response to the chlamydial heat-shock protein 60 in an experimental model of chronic pelvic inflammatory disease in monkeys (Macaca nemestrina). Journal of Infectious Diseases 1999; 180: 774-779.
34. Rank RG, Batteiger BE & Soderberg LSF. Susceptibility to reinfection after primary chlamydial genital infection. Infection and Immunity 1988; 56: 2243-2249.
35. Tuffrey M, Falder P, Gale J et al. Infertility in mice infected genitally with a human strain of Chlamydia trachomatis. Journal of Reproduction and Fertility 1986; 78: 251-260.
36. Stagg AJ, Tuffrey M, Woods C et al. Protection against ascending infection of the genital tract by Chlamydia trachomatis is associated with recruitment of major histocompatibility complex class II antigen-presenting cells into uterine tissue. Infection and Immunity 1998; 66: 3535-3544.
37. Ramsey KH, Newhall WJ & Rank RG. Humoral immune response to chlamydial genital infection of mice with the agent of mouse pneumonitis. Infection and Immunity 1989; 57: 2441-2446.
38. Igietseme JU, Uriri IM, Kumar SN et al. Route of infection that induces a high intensity of gamma interferon-secreting T cells in the genital tract produces optimal protection against Chlamydia trachomatis infection in mice. Infection and Immunity 1998; 66: 4030-4035.
39. Tseng CT & Rank RG. Role of NK cells in early host response to chlamydial genital infection. Infection and Immunity 1998; 66: 5867-5875.
40. Moore T, Ananaba GA, Bolier J et al. Fc receptor regulation of protective immunity against Chlamydia trachomatis. Immunology 2002; 105: 213-221.
41. Zhang YX, Stewart S, Joseph T et al. Protective monoclonal antibodies recognize epitopes located on the major outer membrane protein of Chlamydia trachomatis. Journal of Immunology 1987; 138: 575-581.
42. Cotter TW, Meng Q, Shen ZL et al. Protective efficacy of major outer membrane protein-specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection. Infection and Immunity 1995; 63: 4704-4714.
43. Su H, Morrison RP, Watkins NG & Caldwell HD. Identification and characterization of T helper cell epitopes of the major outer membrane protein of Chlamydia trachomatis. Journal of Experimental Medicine 1990; 172: 203-212.
44. Ortiz L, Demick KP, Petersen JW et al. Chlamydia trachomatis major outer membrane protein (MOMP) epitopes that activate HLA class II-restricted T cells from infected humans. Journal of Immunology 1996; 157: 4554-4567.
45. + CTLs specific for the major outer membrane protein of Chlamydia trachomatis in human genital tract infections. Journal of Immunology 1999; 162: 6855-6866.
46. Ortiz L, Angevine M, Kim SK et al. T-cell epitopes in variable segments of Chlamydia trachomatis major outer membrane protein elicit serovar-specific immune responses in infected humans. Infection and Immunity 2000; 68: 1719-1723.
47. Beagley KW & Timms P. Chlamydia trachomatis infection: incidence, health cost and prospects for vaccine development. Journal of Reproduction and Immunology 2000; 48: 47-68.
48. Pal S, Theodor I, Peterson EM et al. Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein can elicit a protective immune response against a genital challenge. Infection and Immunity 2001; 69: 6240-6247.
49. Igietseme JU & Murdin A. Induction of protective immunity against Chlamydia trachomatis genital infection by a vaccine based on major outer membrane protein-lipophilic immune response-stimulating complexes. Infection and Immunity 2000; 68: 6798-6806.
50. Zhang DJ, Yang X, Berry J et al. DNA vaccination with major outer-membrane protein gene induces aquired immunity to Chlamydia trachomatis (mouse pneumonitis) infection. Journal of Infectious Diseases 1997; 176: 1035-1040.
51. Zhang DJ, Yang X, Shen C & Brunham RC. Characterization of immune responses following intramuscular DNA immunization with the MOMP gene of Chlamydia trachomatis mouse pneumonitis strain. Immunology 1999; 96: 314-321.
52. Shaw AC, Gevaert K, Demol H et al. Comparative proteome analysis of Chlamydia trachomatis serovar A, D and L2. Proteomics 2002; 2: 164-186.
53. Vandahl BB, Gevaert K, Demol H et al. Time-dependent expression and processing of a hypothetical protein of possible importance for regulation of the Chlamydia pneumoniae developmental cycle. Electrophoresis 2001; 22: 1697-1704.
54. Brunham RC, Kuo C-C, Cles L & Holmen KK. Correlation of host immune response with quantitative recovery of Chlamydia trachomatis from human endocervis. Infection and Immunity 1983; 39: 1491-1494.
55. Entrican G, Buxton D, Longbottom D. Chlamydial infection in sheep: Immune control versus fetal pathology. Journal of the Royal Society of Medicine 2001; 94: 273-277.
56. Moore SA, Weite R & Postma MJ. Major improvements in the cost effectiveness of screening women for Chlamydia trachomatis using pooled urine specimens and high performance testing. Sexually Transmitted Infections 2002; 78: 74-75.
57. Ostergaard L, Andersen B, Olesen F & Moller JK. Efficacy of home sampling for screening of Chlamydia trachomatis: randomised study. British Medical Journal 1998; 317: 26-27.